The newly formed Qlarant Capital will invest up to $2m in healthcare technology startups and is being overseen by Qlarant CEO Ron Forsythe.

Qlarant, the US-based healthcare technology company, on Tuesday launched a strategic investment subsidiary, Qlarant Capital, which will fund early-stage healthcare startups.
Initially formed as a quality review service for public healthcare programmes, Qlarant now uses artificial intelligence and predictive modelling to improve business efficiency and cut waste or fraud in government and across in...

Want to read this article?

Subscribe to GCV+

or login to your account

Robert Lavine

Robert Lavine is special features editor for Global Venturing.